Loading clinical trials...
Loading clinical trials...
A Prospective Randomised Controlled Study Demonstrating the Clinical Benefit of Biatain® Ag Relative to Cutimed® Siltec® Sorbact® for the Treatment of Venous Leg Ulcers
Conditions
Interventions
Biatain Ag
Cutimed Siltec Sorbact
Locations
13
United States
Royal Research, Corp.
Hollywood, Florida, United States
Three Rivers Wound and Research Center
North Port, Florida, United States
Detroit foot and ankle Specialists
Clinton Township, Michigan, United States
SerenaGroup Research Center Omaha
Omaha, Nebraska, United States
Serena Group
Monroeville, Pennsylvania, United States
Dermato-Venerologisk Afd
Copenhagen, Denmark
Start Date
June 29, 2023
Primary Completion Date
January 29, 2025
Completion Date
January 29, 2025
Last Updated
May 22, 2025
NCT07372404
NCT07330154
NCT07200401
NCT07261501
NCT07209020
NCT06606210
Lead Sponsor
Coloplast A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions